Walbrook PR, which provides high quality Financial PR and Investor Relations to Small Cap and AIM listed companies, announces its appointment as Financial PR advisor to AIM listed healthcare company Collagen Solutions plc (AIM: COS). Walbrook is ranked No.1 for Healthcare in the AIM Advisers Rankings Guide.
Collagen Solutions plc is a developer and manufacturer of medical grade collagen components for use in regenerative medicine, medical devices and in-vitro diagnostics. Their capabilities include the provision of native, soluble and powdered collagen formulations and expertise in the development and contract manufacture of collagen components for use as tissue scaffolds and medical devices. Collagen Solutions' unique offering extends beyond material supply and contract services, as their highly skilled staff support customers through various stages of development and regulatory approval, establishing long-term commercial relationships.
Paul McManus, Director of Walbrook PR, said: "We are delighted to have been appointed by Collagen Solutions plc as a client. This win further enhances our position as the No. 1 Financial PR agency for AIM listed healthcare clients. Walbrook has built up a very strong position in the Life Sciences space, which combines well with our passion for working with growing businesses."